title: The controversy of hepatitis C and rituximab: A multidisciplinary dilemma with implications for patients with pemphigus.
authors.affiliation: Department of Dermatology, University of California Irvine Medical Center, Irvine, CA, USA.
authors.forename: Kyle T
authors.initials: KT
authors.lastname: Amber
authors.forename: Joyson
authors.initials: J
authors.lastname: Kodiyan
authors.forename: Romi
authors.initials: R
authors.lastname: Bloom
authors.forename: Michael
authors.initials: M
authors.lastname: Hertl
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D019694:Hepatitis B, Chronic / Q000150:complications*; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D008297:Male; D010392:Pemphigus / Q000188:drug therapy*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D003879:Dermatologic Agents